Pancreatic CancerClinical application of functional precision medicine for pancreatic cancer enables personalized treatment prioritization and identification of RAS-targeted combinationsAACR Pancreatic Cancer 2026PosterSeptember 25, 2026
Hematological MalignanciesClinical Utility of Optim.AI™ Precision Oncology Recommendations in Refractory Haematological MalignanciesMSH Annual Scientific Meeting 2026PosterJuly 24, 2026
Breast CancerFunctional Precision Medicine Identifies Oral Fluoropyrimidine Sensitivity in Heavily Pretreated Metastatic Breast Cancer: A Case ReportASCOMOS, 2026 PosterJuly 5, 2026
Pan CancerClinical feasibility study of Optim.AI 2.0, a co-culture high-content functional precision platform for predicting combinatorial immunotherapy responseAACR 2026PosterApril 17, 2026
Pan & Pancreatic CancerReal-world concordance analysis of functional drug sensitivity testing in solid cancers with prospective observational case series of pancreatic cancerAACR 2026PosterApril 17, 2026
Hematological MalignanciesReal-world clinical performance of a combinatorial functional precision platform, Optim.AI™, in hematological malignanciesAACR 2026PosterApril 17, 2026
Gynecological CancersFeasibility study of an ex vivo functional precision medicine platform, Optim.AI™, in guiding treatment for gynecological cancersAACR 2026PosterApril 17, 2026
Soft Tissue SarcomaFunctional precision medicine assay identifies patients with relapsed/refractory Soft Tissue Sarcoma who benefit from Bortezomib-based therapyESMO Rare Cancers 2026PosterMarch 14, 2026
Pancreatic CancerApplying a functional precision medicine platform, Optim.AI, to identify novel KRAS inhibitor-based combinations in pancreatic cancerAACR RAS 2026PosterMarch 6, 2026
Pan CancerClinical evaluation of a high-content functional precision medicine platform for predicting immunotherapy combination responseAACR IO 2026PosterFebruary 19, 2026
